US to cover weight-loss drugs under Medicare/Medicaid
In a landmark decision, US healthcare programmes Medicare and Medicaid will now cover weight-loss medications, including Ozempic, marking a significant shift in obesity treatment policy.
In a landmark decision, US healthcare programmes Medicare and Medicaid will now cover weight-loss medications, including Ozempic, marking a significant shift in obesity treatment policy.